Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Santarus and TAP sign license agreement related to GI diseases

July 12, 2002

Natalizumab is effective and well tolerated in patients with ulcerative colitis

July 9, 2002

Crucell licenses cell line to Korean company for HBV vaccine development

July 8, 2002

FDA approval for Remicade for remission maintenance of Crohn's disease

July 5, 2002

SkyePharma and GeneMedix to develop extended-release interferon alfa-2b

July 5, 2002

Hepatitis B pharmaccine enters phase II

July 3, 2002

Incara submits IND for liver cell transplantation

July 1, 2002

Pegasys approved in E.U.

June 26, 2002

Remicade launched in Japan for Crohn's disease

June 26, 2002

Antiinflammatory activity of IS-741 in experimental colitis

June 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...